Latest Breaking News On - Engitix ltd - Page 1 : vimarsana.com

Engitix Announces Appointment of Matthew Edwards Ph D , as SVP Discovery and Emma Huang Ph D , as VP Data Sciences

Engitix Announces Appointment of Matthew Edwards Ph D , as SVP Discovery and Emma Huang Ph D , as VP Data Sciences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofMike plattGemma huangMatthew edwardsChristopher stevensonGiuseppe mazzaSue charlesDivision of medicineEngitix ltdTranslational sciences for interventional oncologyVp data sciencesHead of data sciences for interventional oncologyInstitute for liverDiscovery sciences of engitixData sciences

Research Report On Global NASH Drug Pipeline Market

Research Report On Global NASH Drug Pipeline Market

South africaUnited statesEli lillyParmeet singhAsia pacificZhejiang doer biologics corpHinova pharmaceuticals incDicerna pharmaceuticals incEngitix ltdChemomab ltdGn corpHeprotech incEnanta pharmaceuticals incDrug pipeline market researchDhirtek business researchHotspot therapeutics inc

Engitix Announces Appointment of Sonia Quaratino, M D , Ph D , as Independent Non-executive Director

Engitix Announces Appointment of Sonia Quaratino, M D , Ph D , as Independent Non-executive Director
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomSonia quaratinoSue charlesEduardo bravoCharles consultantsMike plattGiuseppe mazzaMerck seronoDivision of medicineIchnos sciencesUniversity college londonUniversity of southamptonUniversity of palermoDigestive health

Head-To-Head Survey: ANI Pharmaceuticals (NASDAQ:ANIP) and Morphic (NASDAQ:MORF)

ANI Pharmaceuticals (NASDAQ:ANIP – Get Rating) and Morphic (NASDAQ:MORF – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk. Institutional and Insider Ownership 59.7% of ANI Pharmaceuticals shares are […]

United statesMorphic holding incAbbvie biotechnology ltdJanssen pharmaceuticals incMorphic company profile get ratingPharmaceuticals company profile get ratingEngitix ltdChildren medical center corporationPharmaceuticals incAni pharmaceuticalsGet ratingGiven morphicCompany profileMedical center corporationJanssen pharmaceuticalsNasdaq anip

Engitix Announces Expanded Collaboration and Licensing Agreement with Takeda to Develop New Anti-Fib

Collaboration combines Engitix’s unique human extracellular matrix (ECM) platform with Takeda’s expertise in gastroenterology research and development (R&D) and commercialisationAgreement with Takeda for the discovery and development of novel therapeutics for inflammatory bowel disease (IBD) builds on existing colla.

United kingdomCity ofGiuseppe mazzaMike plattExscalate dompGareth hicksDigestive healthUniversity college londonDivision of medicineEngitix ltdInstitute for liverIbd engitix ltdDiscovery unitWhite city placeNetherton investments